Detalhe da pesquisa
1.
Therapy for minimal residual tumor disease: beta-galactosylceramide inhibits the growth of recurrent HPV16-associated neoplasms after surgery and chemotherapy.
Int J Cancer
; 126(12): 2997-3004, 2010 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19739073
2.
HPV 16-associated tumours: IL-12 can repair the absence of cytotoxic and proliferative responses of tumour infiltrating cells after chemotherapy.
Int J Oncol
; 34(1): 173-9, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19082488
3.
Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours.
Immunology
; 123(2): 218-27, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17725605
4.
IL-12 immunotherapy of minimal residual disease in murine models of HPV16-associated tumours: induction of immune responses, cytokine production and kinetics of immune cell subsets.
Int J Oncol
; 32(2): 499-507, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18202774
5.
The role of immune cell subpopulations in the growth and rejection of TC-1/A9 tumors in novel mouse strains differing in the H2-D haplotype and NKC domain.
Oncol Lett
; 15(3): 3594-3601, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29467880
6.
CpG oligodeoxynucleotides are effective in therapy of minimal residual tumour disease after chemotherapy or surgery in a murine model of MHC class I-deficient, HPV16-associated tumours.
Int J Oncol
; 30(5): 1247-51, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17390028
7.
Immunization with MHC class I-negative but not -positive HPV16-associated tumour cells inhibits growth of MHC class I-negative tumours.
Int J Oncol
; 30(4): 1011-7, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17332942
8.
Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure inhibit prostate tumor growth in TRAMP mice.
Oncoimmunology
; 6(12): e1362528, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29209567
9.
Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours.
Int J Oncol
; 28(1): 253-9, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16328003
10.
Resistance of novel mouse strains different in MHC class I and the NKC domain to the development of experimental tumors.
Int J Oncol
; 49(2): 763-72, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27279019
11.
Tumor growth accelerated by chemotherapy-induced senescent cells is suppressed by treatment with IL-12 producing cellular vaccines.
Oncotarget
; 7(34): 54952-54964, 2016 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27448982
12.
Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy.
Int J Oncol
; 48(3): 953-64, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26718011
13.
Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
Int J Oncol
; 26(2): 521-7, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15645139
14.
HPV16-associated tumours: therapy of surgical minimal residual disease with dendritic cell-based vaccines.
Int J Oncol
; 25(4): 1165-70, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15375569
15.
Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and GM-CSF.
Int J Oncol
; 24(1): 161-7, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14654953
16.
Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
Int J Oncol
; 22(3): 691-5, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12579325
17.
Tumour-inhibitory and antimetastatic effects of IL-2 in mice carrying MHC class I- tumours of HPV16 origin.
Int J Oncol
; 20(3): 643-6, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11836582
18.
DNA demethylating agent 5-azacytidine inhibits myeloid-derived suppressor cells induced by tumor growth and cyclophosphamide treatment.
J Leukoc Biol
; 95(5): 743-753, 2014 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-24389335
19.
Epigenetic regulations in the IFNγ signalling pathway: IFNγ-mediated MHC class I upregulation on tumour cells is associated with DNA demethylation of antigen-presenting machinery genes.
Oncotarget
; 5(16): 6923-35, 2014 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25071011
20.
Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model.
Immunobiology
; 218(6): 851-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23182710